Moreover, a significant decrease in IGFBP-2 mRNA expression was measured in the post-mortem frontal cortex of BD patients, with a specific statistical decrease among patients who were receiving lithium treatment (Bezchlibnyk et al., 2007). The gene discussed is IGFBP2; the disease is Behcet disease.